There’s a reason why most startup ideas focused on modernizing the prescription drug industry have failed: a byzantine system dominated by a group of all-powerful middlemen make an upstart’s chances of success infinitesimal.
Otto Sipe knows this well from nearly a decade of working for both startups and Walmart in and around the pharmacy and medical care spaces. But he thinks he has the right recipe and momentum to prove that he and his Brooklyn-based company can be one of the exceptions.
